Volume 7, Issue 3 (Aug 2019)                   Res Mol Med (RMM) 2019, 7(3): 0-0 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheykhhasan M, Manoochehri H, Samadi P, Kalhor N. Effect of Platelet-rich Plasma and Mesenchymal Stem Cells as two Biological Alternatives in Rotator Cuff Injury Treatment: a mini-review. Res Mol Med (RMM). 2019; 7 (3)
Abstract:   (429 Views)
The rotator cuff injury introduces as significant damage of trauma and others factors, and currently recognized as a prevalent orthopedic problem. Thus, many clinical procedures have been demonstrated to reduce the complication of rotator cuff injury with varying degrees of success. Platelet-rich plasma (PRP) is being enchantingly agreed as one of the most effectiveness strategies for the symptomatic treatment of rotator cuff injury. Many confusing parameters can influence the result of PRP including size of rotator cuff injury, patient age, PRP producing strategy, and number and timing of PRP injections. However, there is some evidences which support beneficial effect PRP in term relieving pain and restoring function, along with minimal adverse effect, in compared with corticosteroids, and other nonsurgical methods. Besides platelet-rich plasma, mesenchymal stem cells (MSCs) are another biological alternative that can be used to treat rotator cuff injuries. Due to lack of large clinical trials applicability, these biological cells have challenges fairly similar to PRP. In conclusion, there is a need for further research to understand the potential application of both of these alternatives as a safe and effective therapeutic option for rotator cuff injuries.
Type of Study: review | Subject: Biotechnology
Received: 2019/09/4

Add your comments about this article : Your username or Email:

Send email to the article author

© 2019 All Rights Reserved | Research in Molecular Medicine

Designed & Developed by : Yektaweb